Harrow Health (HROW) Gets a Buy From Craig-Hallum
Harrow Analyst Ratings
Harrow Analyst Ratings
Harrow Analyst Ratings
Harrow Health's Promising Growth Trajectory and Strong Financial Outlook Reinforce Buy Rating
Harrow Health (HROW) Receives a Buy From Lake Street
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)
Analysts Offer Insights on Healthcare Companies: Rapid Micro Biosystems (RPID), COMPASS Pathways (CMPS) and Harrow Health (HROW)
Harrow Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Lonza Group Ltd (Six Swiss: CH:LONN), Harrow Health (HROW) and Innoviva (INVA)
Harrow Health's Growth Trajectory: A Buy Rating Amid Strong Product Performance and Strategic Market Investments
Lake Street Remains a Buy on Harrow Health (HROW)
Harrow Health (HROW) Gets a Buy From Lake Street
Harrow Health (HROW) Gets a Buy From Lake Street
Harrow Health's Strong Sales Growth and Strategic Acquisitions Fuel Buy Rating
Lake Street Sticks to Their Buy Rating for Harrow Health (HROW)
Lake Street Sticks to Its Buy Rating for Harrow Health (HROW)
Analysts Are Bullish on These Healthcare Stocks: Harrow Health (HROW), Synlogic (SYBX)
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), TELA Bio (TELA) and Harrow Health (HROW)
Analysts Offer Insights on Healthcare Companies: Champions Oncology (CSBR), Walgreens Boots Alliance (WBA) and Harrow Health (HROW)